세계 비뇨기과용 레이저 시장 규모는 2023년 10억 1,985만 달러, 2030년까지 13억 8,283만 달러에 이르고, 2024-2030년의 예측 기간 동안 연평균 5.30% 성장할 전망입니다. 비뇨기과용 레이저에 대한 수요는 요로결석, 방광암, 전립선 질환 등 비뇨기과 관련 질환 환자 증가와 기술 발전 등에 의해 촉진되고 있습니다. 또한, 홀뮴 시스템 및 툴륨 레이저 치료 시스템에서 최소침습적 수술 기법의 채택, 앞서 언급한 질환을 앓고 있는 노인 인구 증가, 전 세계적으로 기기 출시 및 승인 증가 등이 2024-2030년의 예측 기간 동안 비뇨기과용 레이저 시장의 전반적인 성장에 기여할 것으로 예상됩니다.
비뇨기과용 레이저 시장 역학
비뇨기과용 레이저 시장은 다양한 요인으로 인해 제품 수요가 증가하고 있으며, 주요 요인 중 하나는 전 세계적으로 전립선암, 방광암 및 신장 결석 유병률 증가입니다.
세계보건기구(WHO)(2020)에 따르면 전립선암은 남성에서 두 번째로 많이 발생하는 암이며, 전체적으로는 네 번째로 많이 발생하는 암으로, 2020년 전 세계적으로 140만 명 이상의 전립선암 환자가 새로 발생했습니다.
WHO는 또한 2040년까지 약 243만 명의 전립선암 신규 환자가 보고될 것으로 추정하고 있습니다.
또한, 2020년 전 세계적으로 약 57만 3,000건의 방광암이 새로 보고되었으며, 2040년까지 이 숫자는 전 세계적으로 99만 1,000건까지 증가할 것으로 추정되고 있습니다.
또한 세계보건기구(2023년)에 따르면 2021-2022년 200만 명 이상이 신장결석에 걸렸으며, 전 세계 발병률은 매년 3-5%, 평생 유병률은 15-20%에 달할 전망입니다.
따라서 전립선암, 방광암, 신장 결석과 같은 비뇨기과 질환은 비뇨기과용 레이저를 통해 최소 침습적 치료 방법인 비뇨기과용 레이저로 치료할 수 있습니다. 또한 이러한 장치는 더 높은 효율성, 안전성, 빠른 회복 등의 장점이 있습니다. 따라서, 상기 질환의 유병률 증가는 비뇨기과용 레이저에 대한 수요를 증가시켜 예측 기간 동안 비뇨기과용 레이저 시장을 견인할 것으로 예상됩니다.
또한, 레이저 수술은 빠른 치유, 짧은 입원 기간, 적은 출혈, 작은 절개창으로 인한 전신 통증 감소 등의 장점이 있습니다. 이러한 시스템의 신뢰성과 안전성은 시장 확대를 촉진할 것으로 예상됩니다. 또한, 주요 시장 진입 업체들은 정기적인 제품 승인 및 개발에 주력하고 있으며, 이는 예측 기간 동안 시장을 크게 견인할 것으로 예상됩니다. 예를 들어, 올림푸스는 2020년 6월 새로운 솔티브 슈퍼 펄스 레이저 시스템(Soltive SuperPulsed Laser System, Soltive Laser System)을 발표했습니다. 이 새로운 툴륨 파이버 레이저 용도는 연조직 및 결석 분쇄 응용 분야를 위해 개발되었습니다. 따라서 예측 기간 동안 이러한 변수가 시장 확대를 촉진할 것으로 예상됩니다.
그러나 기기 및 시술과 관련된 합병증, 레이저 시스템의 높은 비용 등이 비뇨기과용 레이저 시장의 성장을 저해할 수 있습니다.
비뇨기과용 레이저 시장 부문 분석
비뇨기과용 레이저 시장의 레이저 유형 부문에서는 홀뮴 레이저 시스템 카테고리가 2023년 큰 매출 점유율을 차지할 것으로 예상됩니다. 이는 특수한 방식과 최소 침습적 수술 기법 때문인 것으로 추정됩니다.
홀뮴 레이저는 주로 전립선 수술에 사용되며, 전립선을 통한 소변의 흐름을 방해하는 조직을 제거하기 위해 저침습적 치료가 선호됩니다.
호르미움 시스템에 대한 수요는 절개 수술이 필요 없는 환자 치료에 대한 안전성과 효과로 인해 증가하고 있습니다. 수술 시간은 전립선의 크기에 따라 다르지만 약 45-90분 정도 소요됩니다. 침습이 적기 때문에 환자는 당일 퇴원할 수 있습니다.
또한, 홀뮴 레이저 결석파쇄술은 성공률이 높고, 슈타인슈트라세(체외충격파 결석파쇄술의 합병증으로 결석 파편이 요관을 막는 현상)의 가능성도 낮습니다.
이 보고서는 세계 비뇨기과용 레이저 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 전해드립니다.
Urology Lasers Market By Laser Type (Holmium Laser System, Diode Laser Systems, Thulium Laser System, And Others), Application (Benign Prostatic Hyperplasia, Urolithiasis, Non-Muscle-Invasive Bladder Cancer, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of prostate cancer, kidney stones, bladder cancer, and other urological diseases and the rising demand for minimally invasive surgical procedures
The global urology lasers market was valued at USD 1,019.85 million in 2023, growing at a CAGR of 5.30% during the forecast period from 2024 to 2030 to reach USD 1,382.83 million by 2030. The demand for urology lasers is being boosted by the increase in the number of patients suffering from urology-related disorders such as urolithiasis, bladder cancer, urinary calculi, and prostate diseases and technological advancements, among others. In addition, the adoption of minimally invasive surgical techniques in holmium systems as well as thulium laser treatment systems, the rising burden of the geriatric population suffering from afore-said diseases, and the increasing device launches and approval across the globe among others are thereby contributing to the overall growth of the urology lasers market during the forecast period from 2024-2030.
Urology Lasers Market Dynamics:
The urology lasers market is witnessing a growth in product demand owing to various factors, one of the key factors being the increasing prevalence of prostate cancer, bladder cancer, and kidney stones across the globe.
According to World Health Organization (WHO) 2020, prostate cancer is the second most commonly occurring cancer in men and the fourth most common cancer overall. There were more than 1.4 million new cases of prostate cancer in 2020, across the globe.
The WHO also estimated that nearly 2.43 million new cases of prostate cancer will be reported in 2040.
The above-mentioned also stated that in 2020 nearly 573 thousand new cases of bladder cancer were reported across the globe and this number is estimated to increase to 991 thousand in 2040, globally.
Further, over two million people were affected by renal stone disease in 2021-2022 as per the World Health Organization (2023) with a global incidence of 3-5% annually and a lifetime prevalence of 15-20%.
Thus, urological disorders such as prostate and bladder cancer and kidney stones can be treated using urology laser, a minimally invasive treatment approach. These devices also offer several benefits, such as greater efficiency, safety, and rapid recovery. Therefore, the increasing prevalence of the above-mentioned diseases will increase the demand for urology lasers, thereby driving the market of urology lasers during the forecast period.
Additionally, laser operations have advantages like quicker healing, shorter hospital stays, less blood loss, and less generalized pain due to smaller incisions. Owing to their dependability and safety characteristics, these systems are anticipated to fuel market expansion. Additionally, major market participants are concentrating on regular product approvals and developments, which is anticipated to significantly drive the market throughout the forecast period. For instance, Olympus introduced its new Soltive SuperPulsed Laser System (Soltive Laser System) in June 2020. This new thulium fiber laser application was created for soft tissue and stone lithotripsy applications. Thus, during the anticipated period, these variables are projected to fuel market expansion.
However, complications related to device and procedure, the high cost of laser systems, and others may restrict the urology lasers market growth.
Urology Lasers Market Segment Analysis:
Urology Lasers market by Laser Type (Holmium Laser System, Diode Laser Systems, Thulium Laser System, and Others), Application (Benign Prostatic Hyperplasia, Urolithiasis, Non-Muscle-Invasive Bladder Cancer, and Others), and Geography (North America, Europe, Asia-Pacific, and the Rest of the World)
In the laser type segment of the urology lasers market, the holmium laser system category is expected to amass a significant revenue share in the year 2023. This can be attributed to its special modalities as well as its minimally invasive surgical technique.
Holmium laser is mainly used in prostate surgeries, for which a minimally invasive treatment is preferred for the removal of tissues that blocks urine flow through the prostate.
The demand for holmium systems is increasing due to their safety and effectiveness in the treatment of patients without an incision procedure. The procedure takes about 45-90 minutes depending on the size of the prostate. Since it is a less invasive procedure, the patients get can get discharged on the same day.
Also, holmium laser lithotripsy has higher success rates and decreased chance of steinstrasse (a complication of extracorporeal shockwave lithotripsy in which fragments of the stones block the ureter).
Further, the increasing product launches and approvals will also impact the market of holmium laser systems. For instance, in January 2021, Cook Medical launched Litho EVO holmium laser in the US, Austria, Germany, France, Ireland, Switzerland, and the UK. This laser is indicated for laparoscopic and endoscopic surgical techniques for lithotripsy and soft tissue procedures in urology, gastroenterology, and general surgery.
Thus, the above-mentioned factors are likely to propel the demand for holmium laser systems, thereby contributing to the growth of the urology lasers market during the forecast period from 2024-2030.
North America is expected to dominate the overall Urology Lasers Market:
Among all the regions, North America is estimated to account for the largest share of the Urology Lasers market in the year 2023. This domination is due to the rising prevalence of cancers of the urinary tract, growing preference for minimally invasive procedures due to less operative time and fewer complications, and rising geriatric population base, among others will propel the market of urology lasers in the United States.
According to the American Cancer Society, estimated that about 288,300 new cases of prostate cancer were will diagnosed in the United States in 2023. Also the same source, About 82,290 new cases of bladder cancer (about 62,420 in men and 19,870 in women). The increasing prevalence will also increase the demand for urology lasers as these lasers are used to destroy the tumor present in the body.
The product development activities and product approvals are further expected to drive the product demand in the region. For instance, in May 2022, OmniGuide Holdings (OGH), got the U.S. Food and Drug Administration clearance for RevoLix(TM) HTL a family of pulsed and continuous wave Thulium YAG lasers are the foundation of RevoLix Therapy for urology patients undergoing BPH and Stone Management procedures.
Thus, all the above-mentioned factors will lead to an increase in the North America urology lasers market growth during the forecasting period of 2024-2030.
Urology Lasers Market Key Players:
Some of the key market players operating in the Urology Lasers market include Boston Scientific Corporation, Richard Wolf GmbH., Allengers, B. Braun Melsungen AG, Cook Medical, biolitec® AG, El.En. S.p.A., Olympus, Advanced MedTech., OmniGuide Holdings, Inc., BD, Convergent Laser Technologies, EDAP TMS, Hyperphotonics, GIGAALASER, Asclepion Laser Technologies GmbH, KARL STORZ GmbH, INTERmedic Arfran, IPG Photonics Corporation, Fisioline, and others.
Recent Developmental Activities in the Urology Lasers Market:
In February 2023, Rhein Laser Technologies Ltd., a leading manufacturer of innovative medical lasers for urologic, aesthetic, and physiotherapy markets based in Wuhan and Dusseldorf, launched UroFiber(TM) 150Q which is the world's first 150W SuperPulsed thulium fiber laser (TFL) system, an innovative fiber laser technology for perfectly treating both stone lithotripsy and BPH enucleation.
In September 2021, Olympus launched a urology laser portfolio including iTind, the minimally invasive procedure for the treatment of enlarged prostate, and the SOLTIVE SuperPulsed Laser System for breaking up kidney and ureteral stones.
Key Takeaways from the Urology Lasers Market Report Study
Market size analysis for current urology lasers market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the urology lasers market.
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global urology lasers market.
Various opportunities available for the other competitor in the urology lasers market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current urology lasers market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for urology lasers market growth in the coming future?
Target Audience who can be benefited from this Urology Lasers Market Report Study
Urology lasers products providers
Research organizations and consulting companies
Urology Lasers-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in urology lasers
Various End-users who want to know more about the urology lasers market and the latest technological developments in the urology lasers market.
Frequently Asked Questions for the Urology Lasers Market:
Urological lasers are medical devices used to treat various urological diseases, including benign prostatic hyperplasia, urolithiasis, and non-muscle-invasive bladder cancer.
The global urology lasers market was valued at USD 1,019.85 million in 2023, growing at a CAGR of 5.30% during the forecast period from 2024 to 2030 to reach USD 1,382.83 million by 2030.
The demand for urology lasers is primarily being heightened by the growing geriatric population, increasing prevalence of chronic kidney diseases, increasing figures of prostate cancer, kidney stones, bladder cancer, and other urological diseases, and increasing device launches and approvals, among others, thereby contribute to the overall growth of the urology lasers market during the forecast period from 2024-2030.
Some of the key market players operating in the urology lasers market include Boston Scientific Corporation, Richard Wolf GmbH., Allengers, B. Braun Melsungen AG, Cook Medical, biolitec® AG, El.En. S.p.A., Olympus, Advanced MedTech., OmniGuide Holdings, Inc., BD, Convergent Laser Technologies, EDAP TMS, Hyperphotonics, GIGAALASER, Asclepion Laser Technologies GmbH, KARL STORZ GmbH, INTERmedic Arfran, IPG Photonics Corporation, Fisioline, and others.
North America is expected to dominate the overall urology lasers market during the forecast period from 2024-2030. Factors such as the increasing prevalence of urological disorders, such as bladder cancer and urinary incontinence, the growing preference for minimally invasive procedures due to less operative time and fewer complications, and the presence of key players in the region, among others will positively impact the North America urology lasers market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new drugs, and high awareness about the advantages offered by lasers over other treatment options also helped the market growth in this region.